author-photo

Julie Lejeune

Paris Diderot University

8

Papers

140

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Severe Thrombocytopenia: Final Results of a Multicenter Phase II Study

2020 Blood
Show All
- Source
- Cite
- Save
Citations (1)
A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial

2018 Blood
Show All
- Source
- Cite
- Save
Citations (8)
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group

2018 Haematologica
Show All
- Source
- Cite
- Save
Citations (18)
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: A report by the french Belgian Swiss APL group (APL 2006 trial)

2018 Haematologica
Show All
- Source
- Cite
- Save
Citations (2)
A Phase II Trial of Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Thrombocytopenia

2017 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

2016 Leukemia
Show All
- Source
- Cite
- Save
Citations (77)
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion

2016 Blood
Show All
- Source
- Cite
- Save
Citations (32)